Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.6.1.2 (
guanylate cyclase
)
8,497
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Endostatin is a 20 kDa carboxyl-terminal fragment of collagen XVIII that, when added exogenously, inhibits endothelial proliferation and migration in vitro and angiogenesis and tumor growth in vivo. Previous results showed endostatin/collagen XVIII labeling in few endothelial cells in human glioblastoma multiforme. We have now observed constitutive release of endostatin from one of four endothelial cell lines. Induction of endostatin release was observed after H2O2, an in vitro model of cell stress, CoCl2, a model of hypoxia, and by IFN-gamma challenge. Endostatin expression and release was reduced by the nitric oxide synthase inhibitors aminoguanidine and L-NAME and induced by the NO synthase-independent NO donors sodium nitroprusside (SNP) and spermine-
NONO
-ate. SNP-mediated endostatin induction was abrogated by the soluble
guanylate cyclase
inhibitor 1H-(1.2.4) oxadiazolo (4,3-A) quinoxalin-1-one. Adenoviral endostatin transduction resulted in the release of endostatin from endothelial cells and in down-regulation of iNOS (NOS2) and eNOS (NOS3), and surprisingly in a 10% induction of PCNA. These results describe the modulation of endostatin release by the NO signaling cascade and provide important new pharmacological information for the systemic induction of endogenous endostatin release by common NO donor pharmacotherapy.
...
PMID:Endothelial endostatin release is induced by general cell stress and modulated by the nitric oxide/cGMP pathway. 1283 91
The influence of streptonigrin on the activity of human platelet
guanylyl cyclase
was investigated. Streptonigrin (0.1-5 microM) had no effect on the basal activity of the enzyme, but inhibited in a concentration-dependent manner the sodium nitroprusside-induced activation of human platelet soluble guanylyl cyclase with an IC(50) value of 4.16 microM. Streptonigrin (10 microM) also inhibited (by 28%) the activation of the enzyme by the direct nitric oxide (NO) donor-spermine-
NONO
(100 microM), but had no influence on the stimulation of soluble guanylyl cyclase by protoporphyrin IX. The absence of a correlation between the inhibition of NO-stimulated
guanylyl cyclase
activity by streptonigrin (I) and its derivatives (streptonigrone (IV), streptonigrone-2'-imine (V), amide of 1 and 2'-deoxy-2'-amino-D-glucose (VI), amide of 1 and 2'-deoxy-2'-amino-2'-D-galactose (VII), amide of 1 and 1-O-methyl-6-deoxy-6-amino-D-glucose (VIII), diphenylmethyl ester of I (IX), conjugate of I and daunorubicin (X)), and the level of cytotoxic effects of these compounds excludes the involvement of
guanylyl cyclase
in the mechanism of antitumor action of streptonigrin. Inhibition of
guanylyl cyclase
activation by NO donors but not by protoporphyrin IX represents a new biochemical effect of streptonigrin, which should be taken into account in addition to its antitumor action.
...
PMID:Antitumor antibiotic streptonigrin and its derivatives as inhibitors of nitric oxide-dependent activation of soluble guanylyl cyclase. 1472 99
Intracellular calcium transients in skeletal muscle cells initiate phenotypic adaptations via activation of calcineurin and its effector nuclear factor of activated t-cells (NFAT). Furthermore, endogenous production of nitric oxide (NO) via calcium-calmodulin-dependent NO synthase (NOS) is involved in skeletal muscle phenotypic plasticity. Here, we provide evidence that NO enhances calcium-dependent nuclear accumulation and transcriptional activity of NFAT and induces phosphorylation of glycogen synthase kinase-3beta (GSK-3beta) in C2C12 myotubes. The calcium ionophore A23187 (1 microM for 9 h) or thapsigargin (2 microM for 4 h) increased NFAT transcriptional activity by seven- and fourfold, respectively, in myotubes transiently transfected with an NFAT-dependent reporter plasmid (pNFAT-luc, Stratagene). Cotreatment with the NOS-inhibitor N(G)-nitro-L-arginine methyl ester (L-NAME; 5 mM) or the
guanylate cyclase
inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ; 10 microM) prevented the calcium effects on NFAT activity. The NO donor diethylenetriamine-
NONO
(DETA-NO; 10 microM) augmented the effects of A23187 on NFAT-dependent transcription. Similarly, A23187 (0.4 microM for 4 h) caused nuclear accumulation of NFAT and increased phosphorylation (i.e., inactivation) of GSK-3beta, whereas cotreatment with L-NAME or ODQ inhibited these responses. Finally, the NO donor 3-(2-hydroxy-2-nitroso-1-propylhydrazino)-1-propanamine (PAPA-NO; 1 microM for 1 h) increased phosphorylation of GSK-3beta in a manner dependent on
guanylate cyclase
activity. We conclude that NOS activity mediates calcium-induced phosphorylation of GSK-3beta and activation of NFAT-dependent transcription in myotubes. Furthermore, these effects of NO are
guanylate cyclase
-dependent.
...
PMID:Nitric oxide facilitates NFAT-dependent transcription in mouse myotubes. 1827 17
The influence of adrenochrome and YC-1 on spermine
NONO
-induced activation of human soluble guanylyl cyclase was investigated. Adrenochrome (0.1-10 microM) had no effect on the basal activity, but it potentiated in concentration-dependent manner the spermine
NONO
-induced activation of this enzyme. Adrenochrome, like YC-1, sensitized
guanylyl cyclase
towards nitric oxide (NO) and produced the leftward shift of spermine
NONO
concentration responce curve. Addition of adrenochrome decreased the YC-1-induced leftward shift of spermine
NONO
concentration response curve. Adrenochrome also inhibited (by 63%) the enzyme activation by YC-1. These data demonstrates the possible competition between adrenochrome and YC-1. Thus, synergistic activation of NO-stimulated
guanylyl cyclase
activity by adrenochrome represents a new biochemical effect of this compound and indicates that adrenochrome may act as an endogenous regulator of NO-dependent stimulation of soluble guanylyl cyclase. This new property of adrenochrome, similar to YC-1, is necessary taking into account, especially under conditions of overproduction of adrenochrome in organism.
...
PMID:[YC-1-like potentiation of nitric oxide-dependent activation of soluble guanylyl cyclase by adrenochrome]. 1920 27
The influence of antibiotics laevomycetin and tetracycline and the antivirus agent oxolin on the activity of human platelet soluble
guanylate cyclase
, the stimulation of the enzyme by NO-donors (sodium nitroprusside (SNP) and spermine nanoate (spermine
NONO
)) and the combination of spermine
NONO
and YC-1 was investigated. All preparations used in the concentration range 0,1-10 mM had no effect on the basal activity of
guanylate cyclase
but potentiated the SNP-induced activation of this enzyme. All preparations used synergistically increased (similar to YC-1) spermine
NONO
-induced activation of soluble
guanylate cyclase
. At the same time these compounds did not produce the leftward shift of spermine
NONO
concentration response curve characteristic for YC-1. Moreover, all compounds used did not influence the leftward shift of spermine
NONO
concentration response curve obtained in the presence of YC-1. This demonstrated that there was no competition between YC-1 and the drugs for interaction with the enzyme. The revealed regulatory phenomen of laevomycetin, tetracycline and oxolin to increase synergistically NO-dependent activation of soluble
guanylate cyclase
may cause additional pharmacological effects during prolong treatment by these drugs. This fact is necessary taking into account.
...
PMID:[Potentiation of nitric oxide-dependent activation of soluble guanylate cyclase by levomycetin, tetracycline, and oxolin]. 1966 5
Isatin (indole-dione) is an endogenous indole that exibits a wide range of biological and physiological activity. The influence of isatin derivatives 5-nitroisatin and arbidol (an antiviral preparatation) on spermine
NONO
-induced activation of human platelet soluble guanylyl cyclase was investigated. 5-nitroistnin and arbidol had no effect on basal activity, but synergistically increased in a concentration-dependent manner the spermine
NONO
-induced activation of this enzyme. 5-Nitroisatin and arbidol, like YC-1, sensitized
guanylyl cyclase
towards nitric oxide (NO) and produced a leftward shift of the spermine
NONO
concentration response curve. At the same time both compounds used did not influence the activation of
guanylyl cyclase
by YC-1 and did not change the synergistic increase of spermine
NONO
-induced activation of soluble guanylyl cyclase in the presence of YC-1. This suggests that 5-nitroisanin and arbidol did not compete with YC-1. Addition of isatin did not change the synergistic increase in the spermine
NONO
-induced
guanylyl cyclase
activation by 5-nitroisatin and arbidol and did not influence a leftward shift of spermine
NONO
concentration response curve produced by these compounds. These data suggest lack of competitive interaction between isatin and both its derivatives used.
...
PMID:[Potentiation of NO-dependent activation of soluble guanylyl cyclase by 5-nitroisatin and antiviral preparatation arbidol]. 2398 67